| 摘要 |
The present invention provides formulations that prevent loss and damage of PEG-interferon alpha conjugates during and following lyophilization. The formulations of the present invention protect PEG-interferon alpha conjugate s from loss and degradation during the lyophilization process, as well as degradation during subsequent storage. The formulations of the present invention are suitable for protection of PEG-interferon alpha conjugates fro m various types of degradation, including, but not limited to loss of biologic al activity and changes in the degree and/or nature of conjugation. A preferred PEG-interferon alpha conjugate protectable in the formulations of the presen t invention is an interferon alpha-2b-polyethylene glycol (12,000) conjugate.< /SDOAB>
|
